Código QR (código de barras bidimensional)

Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma

Abstract Background The efficacy of immunotherapy targeting the PD-1/PD-L1 pathway has previously been demonstrated in metastatic head and neck squamous cell carcinoma (HNSCC). Stereotactic Body Radiotherapy (SBRT) aims at ablating metastatic lesions and may play a synergistic role with immunotherap...

Fuld beskrivelse

Na minha lista:
Principais autores: Houda Bahig, Francine Aubin, John Stagg, Olguta Gologan, Olivier Ballivy, Eric Bissada, Felix-Phuc Nguyen-Tan, Denis Soulières, Louis Guertin, Edith Filion, Apostolos Christopoulos, Louise Lambert, Mustapha Tehfe, Tareck Ayad, Danielle Charpentier, Rahima Jamal, Philip Wong
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2019-01-01
Serier:BMC Cancer
Fag:
Head and neck cancer
Metastatic
Immunotherapy
SBRT
Durvalumab
Tremelimumab
Online adgang:http://link.springer.com/article/10.1186/s12885-019-5266-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker